Home > Financial Ratios > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
EV/Core EBITDA

    Back to All Ratios
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 71.2158.3639.8458.8548.37

What is the latest EV/Core EBITDA ratio of ASTRAZENECA PHARMA INDIA ?

The latest EV/Core EBITDA ratio of ASTRAZENECA PHARMA INDIA is 71.21 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202571.21
Mar202458.36
Mar202339.84
Mar202258.85
Mar202148.37

How is EV/Core EBITDA of ASTRAZENECA PHARMA INDIA Trending?

Years EV/Core EBITDA % Change
Mar2025 71.21
22.02
Mar2024 58.36
46.49
Mar2023 39.84
-32.30
Mar2022 58.85
21.67
Mar2021 48.37 -

Other Financial Ratios of ASTRAZENECA PHARMA INDIA


Compare EV/Core EBITDA ratio of peers of ASTRAZENECA PHARMA INDIA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA ₹21,678.6 Cr 0.8% 2.5% 8.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,096.0 Cr -2.4% 3% 9.6% Stock Analytics
DIVIS LABORATORIES ₹176,807.0 Cr -3.3% 3.5% 4.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,718.0 Cr -2% 5% 43.1% Stock Analytics
CIPLA ₹112,971.0 Cr -0% 6.9% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,752.0 Cr -0.3% -3.8% 7.3% Stock Analytics


ASTRAZENECA PHARMA INDIA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA

0.8%

2.5%

8.6%

SENSEX

-0.5%

-3.3%

-7.6%


You may also like the below Video Courses